According to Dr Jason Kaplan, an wholistic cardiologist from Sydney, the cholesterol story is changing.
When it comes to prevention of cardiovascular disease, cholesterol and LDL is only part of the picture. The reality is that the majority of people who are treated for heart attacks have normal cholesterol levels.
Migraine is a severe neurological disorder that affects a significant proportion of the population. Prevalence estimates vary between 12 and 25% depending on the population studied. The disorder has a significant genetic component.
In this interview, Andrew talks to Professor Lyn Griffiths on her very promising research which looks at genetic profiling in conjunction with nutraceutical therapies. These clinical trials highlight the potential importance of nutritional interventions in this disorder.
Many would be familiar with Dr Murray and his extensive body of work in the field of complementary medicine research. He has published almost 30 books, selling over two million copies, including the seminal clinical reference Textbook of Natural Medicine. He has compiled a database of more than 50,000 scientific studies in the medical literature which provide the strong evidence that natural measures are effective at maintaining good health and treating disease.
In this, second part of a two part interview with Australia's leading nutritional biochemist, Dr Robert Buist they continue to explore the latest in cholesterol research and its implication to our understanding of cardiovascular health and disease prevention.
Rethinking the Cholesterol Paradigm Part 1 is a two part audio interview with Dr Robert Buist, Australia's leading nutritional biochemist. This podcast looks into the latest in cholesterol research and explores the exciting new directions unfolding in our understanding of cardiovascular health and disease prevention.